CANCER SURVIVAL TIPS
Experimental treatment sends deadly leukemia into remission
- ‘Unbelievable’ success for small pilot study
- Treatment buys critical time for patients seeking potentially life-saving transplant
- Cutting-edge combo pairs immune therapy, manipulation of gene activity
- Drugs already approved by the Food and Drug Administration
- Study ‘proof of principle’ for treating many other cancers as well
Avocados may hold the answer to beating leukemia
Rich, creamy, nutritious and now cancer fighting. New research reveals that molecules derived from avocados could be effective in treating a form of cancer.
Professor Paul Spagnuolo from the University of Waterloo has discovered a lipid in avocados that combats acute myeloid leukemia (AML) by targeting the root of the disease – leukemia stem cells. Worldwide, there are few drug treatments available to patients that target leukemia stem cells.
USF researchers develop novel ketone supplements to enhance non-toxic cancer therapy
The mouse model study combined a ketogenic diet and supplements with hyperbaric oxygen therapy
Tampa, FL (June 10, 2015) — A team of researchers from the Hyperbaric Biomedical Research Laboratory at the University of South Florida (USF) has doubled survival time in an aggressive metastatic cancer model using a novel combination of non-toxic dietary and hyperbaric oxygen therapies.
The study, “Non-toxic metabolic management of metastatic cancer in VM mice: Novel combination of ketogenic diet, ketone supplementation, and hyperbaric oxygen therapy,” was published online today in PLOS ONE.
Certain Donors with High T Cell Counts Make a Better Match for Stem-Cell Transplant Patients, Penn Study Suggests
Screening for T Cell Characteristics May Optimize Donor Selection for Older Blood Cancer Patients
PHILADELPHIA – Using a simple blood test to measure the T lymphocyte count in donors for stem cell transplants may help identify the best match for patients in need of an allogeneic stem cell transplant, suggests a new study in the Journal of Clinical Oncology from researchers at the Abramson Cancer Center (ACC) of the University of Pennsylvania. Typically, matched siblings have been preferred over unrelated donors. This study shows that older patients who received stem cells from younger, unrelated donors with higher numbers of so-called killer T cells (CD8 cells) had significantly reduced risk of disease relapse and improved survival compared to those who received stem-cells from donors with low numbers of CD8 cells, including older matched siblings.
Intravenous Nutrition Source Could Improve Effectiveness of Chemotherapy Nanodrugs
A single dose of an FDA-approved intravenous nutrition source may be able to significantly reduce the toxicity and increase the bio-availability of platinum-based cancer drugs, according to a study by Carnegie Mellon University biologists published in Scientific Reports.